[go: up one dir, main page]

AR247405A1 - Procedimiento de preparacion de polipeptidos inmunologicamente activos y juego de diagnostico que los comprende. - Google Patents

Procedimiento de preparacion de polipeptidos inmunologicamente activos y juego de diagnostico que los comprende.

Info

Publication number
AR247405A1
AR247405A1 AR87309456A AR30945687A AR247405A1 AR 247405 A1 AR247405 A1 AR 247405A1 AR 87309456 A AR87309456 A AR 87309456A AR 30945687 A AR30945687 A AR 30945687A AR 247405 A1 AR247405 A1 AR 247405A1
Authority
AR
Argentina
Prior art keywords
group
amino acid
preparation
aminic
polypeptide
Prior art date
Application number
AR87309456A
Other languages
English (en)
Original Assignee
Eniricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eniricerche Spa filed Critical Eniricerche Spa
Application granted granted Critical
Publication of AR247405A1 publication Critical patent/AR247405A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PREPARACION DE POLIPEPTIDOS IMNUNOLOGICAMENTE ACTIVOS DE FORMULA (I), QUE COMPRENDE LAS ETAPAS DE: (A) CONDENSAR EL PRIMER AMINOACIDO (ALA) PROTEGIDO AL GRUPO - AMINICO A UN SOPORTE INSOLUBLE POR UNA REACCION DE ESTERIFICACION ENTRE EL GRUPO CARBOXILICO ACTIVADO Y EL GANCHO DE CONEXION DEL SOPORTE SOLIDO; (B) REMOVER EL GRUPO PROTECTOR DEL GRUPO - AMINO; (C) CONDENSAR EL AMINOACIDO ALA LIGADO EN SOPORTE SOLIDO INSOLUBLE AL SEGUNDO AMINOACIDO ASN PROTEGIDO AL GRUPO - AMINICO POR MEDIO DE REACCION DE ACILACION ENTRE EL GRUPO AMINICO DESPROTEGIDO Y EL GRUPO CARBOXILICO ACTIVADO DEL SEGUNDO AMINOACIDO; (D) REMOVER EL GRUPO - AMINICO PROTECTOR DEL SEGUNDO AMINOACIDO; (E) CONDENSAR LOS SUCESIVOS AMINOACIDOS PROTEGIDOS A LAS FUNCIONALIDADES EN CADENA LATERAL, HASTA COMPLETAR EL POLIPEPTIDO (I); (F) DESBLOQUEAR EL POLIPEPTIDO (I) POR MEDIO DE HIDROLISIS ACIDA; (G) RECUPERAR Y PURIFICAR EL POLIPEPTIDO (I) POR MEDIO DE CROMATOGRAFIA.
AR87309456A 1986-12-04 1987-12-01 Procedimiento de preparacion de polipeptidos inmunologicamente activos y juego de diagnostico que los comprende. AR247405A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22560/86A IT1198225B (it) 1986-12-04 1986-12-04 Polipeptidi immunologicamente attivi utili per la preparazione di vaccini antimalaria e di kits diagnostici per la determinazione di anticorpi antisporozoita

Publications (1)

Publication Number Publication Date
AR247405A1 true AR247405A1 (es) 1994-12-29

Family

ID=11197840

Family Applications (1)

Application Number Title Priority Date Filing Date
AR87309456A AR247405A1 (es) 1986-12-04 1987-12-01 Procedimiento de preparacion de polipeptidos inmunologicamente activos y juego de diagnostico que los comprende.

Country Status (16)

Country Link
US (1) US4843146A (es)
AR (1) AR247405A1 (es)
AT (1) AT398426B (es)
BE (1) BE1001692A5 (es)
CA (1) CA1304888C (es)
CH (1) CH672491A5 (es)
DE (1) DE3741183A1 (es)
ES (1) ES2005753A6 (es)
FR (1) FR2607703B1 (es)
GB (1) GB2199038B (es)
GR (1) GR871850B (es)
IT (1) IT1198225B (es)
NL (1) NL8702921A (es)
OA (1) OA08782A (es)
SE (1) SE8704765L (es)
ZA (1) ZA878903B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1198233B (it) * 1986-12-23 1988-12-21 Eniricerche Spa Metodo per la determinazione di anticorpi antisporozoita di p. falciparum nel sangue umano
IT1223301B (it) * 1987-09-11 1990-09-19 Eniricerche Spa Polipeptidi sequenziali immunologicamente attivi
IT1217582B (it) * 1988-05-13 1990-03-30 Eniricerche Spa Metodo immunoenzimatico in fase omogenea per la determinazione di anticorpi antisporozoita di plasmodium falciparum nel sangue umano
US5028425A (en) * 1988-07-07 1991-07-02 The United States Of America As Represented By The Department Of Health And Human Services Synthetic vaccine against P. falciparum malaria
CA2006700A1 (en) * 1989-01-17 1990-07-17 Antonello Pessi Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
DE69014150T2 (de) * 1989-05-19 1995-05-11 Eniricerche Spa Immunogen-Verbindungen und deren Benutzung in der Herstellung von genetisch unbeschränkten synthetischen Impfstoffen und bei der immunoenzymatischer Bestimmung von antisporozoiden Antikörpern von Plasmodium malariae.
IT1237764B (it) * 1989-11-10 1993-06-17 Eniricerche Spa Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
US6942866B2 (en) * 2000-08-16 2005-09-13 Apovia, Inc. Malaria immunogen and vaccine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
CN86100979A (zh) * 1985-02-07 1986-12-17 史密丝克莱恩贝克曼公司 疟疾疫苗的制备方法
WO2000000911A1 (en) * 1998-06-29 2000-01-06 Sbc Technology Resources, Inc. Emergency facility information system and methods

Also Published As

Publication number Publication date
ES2005753A6 (es) 1989-03-16
GB2199038B (en) 1991-03-20
AT398426B (de) 1994-12-27
DE3741183A1 (de) 1988-06-09
DE3741183C2 (es) 1991-06-06
IT8622560A0 (it) 1986-12-04
OA08782A (en) 1989-03-31
BE1001692A5 (fr) 1990-02-13
SE8704765L (sv) 1988-06-05
GR871850B (en) 1988-03-24
GB2199038A (en) 1988-06-29
ZA878903B (en) 1988-05-26
CA1304888C (en) 1992-07-07
FR2607703B1 (fr) 1993-09-24
ATA319087A (de) 1994-04-15
NL8702921A (nl) 1988-07-01
GB8728000D0 (en) 1988-01-06
US4843146A (en) 1989-06-27
SE8704765D0 (sv) 1987-11-30
IT1198225B (it) 1988-12-21
FR2607703A1 (fr) 1988-06-10
CH672491A5 (es) 1989-11-30

Similar Documents

Publication Publication Date Title
Sakakibara et al. A new method for releasing oxytocin from fully-protected nona-peptides using anhydrous hydrogen fluoride
NO20070618L (no) Forbindelser og fremgangsmater for immunterapi og diagnose av tuberkulose.
EP0225066A3 (en) Antigen determinant peptides and a process for the preparation thereof
CA2187083A1 (fr) Fragment peptidique de la proteine g du virus respiratoire syncytial, agent immunogene, composition pharmaceutique le contenant et procede de preparation
AR247405A1 (es) Procedimiento de preparacion de polipeptidos inmunologicamente activos y juego de diagnostico que los comprende.
ES8205754A1 (es) Procedimiento de preparacion de un nuevo ester octapeptido
DK261384A (da) Renset hematoporphyrinderivat til diagnose og behandling af tumorer
ES2061479T3 (es) Aminouretanos, procedimiento de obtencion y usos.
ES487046A1 (es) Procedimiento de preparacion de proteoglicanos membranarios bacterianos purificados
DE69609845D1 (de) Verfahren zur Herstellung von Epirubicin oder Zusatzsalzen davon, von Daunorubicin
DK0909323T3 (da) Helicobacter pylori-bakterioferritin
AR035077A1 (es) Polipeptidos de neublastina variante, proteinas de fusion, acidos nucleicos, vectores, celulas hospedadoras, metodos para producir dichos polipeptidos, dimeros, conjugados, composiciones farmaceuticas y uso de dichos polipeptidos en la preparacion de medicamentos
DE69004353D1 (de) Verfahren zur Reinigung von Tryptophan.
ES2039239T3 (es) Vacuna contra el virus varicela-zoster.
PT81345B (pt) Processo para a preparacao de novos peptideos activos sobre o sistema nervoso central com accao sobre o sistema colinergico, e de composicoes farmaceuticas contendo estes compostos
ATE56139T1 (de) Verfahren zur herstellung einer waessrigen pharmazeutischen loesung einer organischen saeure als wirkstoff.
SE8701628D0 (sv) Medel for analys mm
ES2108684T3 (es) Analogo de la hormona de liberacion de la hormona luteinizante (lhrh).
Lederer et al. Subunits of Bakers' Yeast Cytochrome b2 (l‐Lactate Cytochrome c Oxidoreductase) 2. End Groups and Origin of Microheterogeneity
Pyle et al. Purification and characterization of the external envelope glycoprotein from two human immunodeficiency virus type 1 variants, HTLV-IIIB and HTLV-IIIRF
PT87239A (pt) Process for the preparation of peptides
MX168650B (es) Procedimiento para concentrar una solucion acuosa de un aminoacido
HU906421D0 (en) Process for testing analogous peptides of hiv
BE1000167A4 (fr) Antigene du virus de l'hepatite b et procede pour sa production.
US7205102B1 (en) Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated virus (LAV) and proteins encoded by said LAV genomic RNA